ILK knockdown in SKOV3 cells results in tumor growth inhibition: To validate the findings obtained using a transient knockdown of ILK-1 using siRNAs, ILK was knocked down stably in SKOV3 cells using CRISPR/Cas9 sgRNA lentiviral constructs. Here, ILK is linked to neoplasm.